LifeVantage
May 6, 2025
SALT LAKE CITY, May 6, 2025 --
LifeVantage reported fiscal third-quarter 2025 revenue of 58.4 million dollars, up 21.1 percent from a year earlier, driven by its MindBody GLP-1 System. Revenue in the Americas rose 29.5 percent, including 31.4 percent growth in the United States, while Asia/Pacific and Europe fell 7.2 percent. The company also launched its Evolve compensation plan in Asia during the quarter.
Net income was 3.5 million dollars, or 0.26 dollars per diluted share, compared with 0.13 dollars a year earlier. Adjusted EBITDA rose to 6.4 million dollars from 5.1 million dollars, and gross margin was 81.0 percent.
The company lowered its fiscal 2025 revenue guidance to 228 million to 235 million dollars from 235 million to 245 million dollars, while reiterating its outlook for adjusted EBITDA of 21 million to 24 million dollars and adjusted earnings of 0.72 to 0.88 dollars per share. LifeVantage ended the quarter with 22.5 million dollars in cash and no debt and declared a quarterly dividend of 0.045 dollars per share. Steve Fife is president and chief executive.